Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
40–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female of age greater than or equal to 40 years.
Spirometrically confirmed COPD according to diagnostic criteria in Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2016.
A treated exacerbation of COPD within 3 months prior to the study visit.
Willing and able to provide informed consent, and able to participate in focus groups or cognitive interviews.
Literacy is not a requirement for any of the groups.
You may not be if
Current diagnosis of asthma or clinically relevant bronchiectasis. Note: Subjects with Asthma COPD Overlap Syndrome (ACOS) are eligible.
Subjects with a concurrent significant, uncontrolled, active medical condition or disease state of other organ diseases or systematic diseases; psychiatric condition; cognitive impairment or any other reasons that in the investigator's opinion, would place subjects at risk or interfere with study evaluation or affect participation in the study.
Clareo Health | Accurate Recognition of Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)
